SCHEMBL13386366

SCHEMBL13386366

CNC(=O)[C@H](C)N(C)c1cc(=O)c(O)cn1C

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 9/20 0.35
APP P05067 2/20 0.33
TYR P14679 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1077539 0.75 BRD4 (0.41) BRD4
SCHEMBL9012839 0.73 APP (0.42) APPTYRHRH3
SCHEMBL13386368 0.69 TYR (0.36) APPTYR
SCHEMBL18467745 0.62 MAPT (0.39) APPTYR
SCHEMBL15100202 0.61 APP (0.44) BRD4APPTYR
SCHEMBL15991636 0.60 CCNC (0.49) BRD4APPTYR
SCHEMBL23139408 0.59 APP (0.45) APPTYR
SCHEMBL4774585 0.59
SCHEMBL2117658 0.59 APP (0.41) APPTYR
SCHEMBL13467616 0.58 TYR (0.46) APPTYRHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9938240-B2 Fluorinated derivatives of 3-hydroxypyridin-4-ones APOTEX INC. (CA) 2018-04-10 US disclosed
US-20170247329-A1 \"Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones\ APOTEX TECHNOLOGIES INC. (CA) 2017-08-31 US disclosed
US-20170088518-A1 Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones THE BANK OF NOVA SCOTIA (CA) 2017-03-30 US disclosed
US-9550733-B2 Fluorinated derivatives of 3-hydroxypyridin-4-ones APOTEX TECHNOLOGIES INC. (CA) 2017-01-24 US disclosed
US-20160083346-A1 Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones APOTEX TECHNOLOGIES INC. (CA) 2016-03-24 US disclosed
US-20150335626-A1 FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES APOTEX INC. (CA) 2015-11-26 US disclosed
US-20150274665-A1 FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES FLORIDA TURBINE TECHNOLOGIES, INC. 2015-10-01 US disclosed
US-9073865-B2 Fluorinated derivates of 3-hydroxypyridin-4-ones APOTEX TECHNOLOGIES INC. (CA) 2015-07-07 US disclosed
EP-2448922-B1 FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES APOTEX TECHNOLOGIES INC (CA) 2014-08-20 EP disclosed
CN-102712591-B Fluorinated derivatives of 3-hydroxypyridin-4-ones APOTEX TECHNOLOGIES INC 2014-06-25 CN disclosed
CN-103601673-A Fluorinated derivatives of 3-hydroxypyridin-4-ones APOTEX TECHNOLOGIES INC 2014-02-26 CN disclosed
US-20120270882-A1 FLUORINATED DERIVATES OF 3-HYDROXYPYRIDIN-4-ONES APOTEX TECHNOLOGIES INC. (CA) 2012-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160083346-A1 Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones FH, FECH, FPGS BRD4 3578/4885APP 2818/4885TYR 578/4885
US-20150335626-A1 FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES FH, FECH, TFRC BRD4 3629/4885APP 3600/4885TYR 332/4885
US-20120270882-A1 FLUORINATED DERIVATES OF 3-HYDROXYPYRIDIN-4-ONES FH, FECH, FTH1 BRD4 3392/4885APP 3527/4885TYR 327/4885
US-20170088518-A1 Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones FH, FECH, FPGS BRD4 3795/4885APP 3156/4885TYR 586/4885
US-20170247329-A1 \"Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones\ FH, FECH, FPGS BRD4 4034/4885APP 2896/4885TYR 641/4885
US-20150274665-A1 FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES FH, FECH, TFRC BRD4 3629/4885APP 3600/4885TYR 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.